MENU
PTN
Stock ticker: ASE
PRICE
CHANGE
CAPITALIZATION
Palatin Technologies (PTN) Ownership - Who owns Palatin Technologies?
Palatin Technologies Inc is a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system... Show more
Industry: #Biotechnology
Profile
Industry
Biotechnology
Address
4B Cedar Brook Drive
Phone
+1 609 495-2200
Employees
34
Web
https://www.palatin.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
20.09M
P/E Ratio
N/A
Total Cash
3.42M
Projected Growth
N/A
Total Debt
357.74K
Revenue
350K
Risk (Beta)
0.78
Dividend Yield
N/A
Total Cash/Share
0.13
Total Debt/Equity
0.02
Revenue/Share
0.02 USD as % of share price
Fundamentals
PTN
Capitalization
20.1M
P/E Ratio
N/A
Risk (Beta)
0.78
Dividend Yield
N/A
Total Cash
3.42M
Total Cash/Share
0.13
Total Debt
358K
Total Debt/Equity
0.02
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
350K
ROE
N/A
Book Value
-6.38M
P/B Ratio
10.31
Cash Flow
N/A
Earnings
-1.54
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
235K
Current Ratio
0.38
Current Revenue Per Employee
61639.79
Dividends Per Share - Security
N/A
EBITDA
-26.62M
Float
N/A
Float - Current
N/A
Gross Income Margin
95.20
Revenue To Assets
-301.74
Shares Held By Institutions
278M
Shares Outstanding - Current
26M
Total Liabilities
10.7M
Total Volume MTD
N/A
Value
-1
Gain YTD
-30.405
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a developer of peptide, peptide mimetic and small molecule agonist compounds
Industry Biotechnology
Profile
Fundamentals
Details
Industry
Biotechnology
Address
4B Cedar Brook Drive
Phone
+1 609 495-2200
Employees
34
Web
https://www.palatin.com